Search results for " DIABETES MELLITUS"

showing 10 items of 309 documents

Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.

2018

Nonalcoholic fatty liver disease (NAFLD) affects 25% of the global adult population with a range of 13.5% in Africa and 31.8% in the Middle East. Nonalcoholic fatty liver disease is closely associated with a constellation of metabolic comorbidities which include: obesity, type 2 diabetes mellitus, hypertension, and hypercholesteremia. In fact, the increasing number of metabolic comorbidities not only increases the prevalence of NAFLD but also places patients at higher risk for progressive liver disease. As such, NAFLD is presently among the top etiologies for hepatocellular carcinoma and an indication for liver transplantation (LT) in the United States. Therefore, the following recommendati…

United StateLiver Cirrhosismedicine.medical_specialtyCarcinoma HepatocellularTissue and Organ ProcurementWaiting ListsLiver Cirrhosimedicine.medical_treatmentComorbidity030230 surgeryLiver transplantationdigestive system03 medical and health sciencesLiver disease0302 clinical medicineNon-alcoholic Fatty Liver DiseaseRisk FactorsInternal medicineEpidemiologyNonalcoholic fatty liver diseasePrevalenceMedicineHumansMetabolic SyndromeTransplantationbusiness.industryRisk FactorIncidencePatient SelectionLiver Neoplasmsnutritional and metabolic diseasesType 2 Diabetes Mellitusmedicine.diseaseComorbidityObesitydigestive system diseasesUnited StatesLiver TransplantationLiver NeoplasmWaiting ListDisease Progression030211 gastroenterology & hepatologyMetabolic syndromebusinessHumanTransplantation
researchProduct

Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ concentration in subjects with vascular atherosclerotic disease subdivided according…

2006

An abnormal activation state of polymorphonuclear leukocytes (PMN) plays a key role in organ injury induced by vascular atherosclerotic disease (VAD) and diabetes mellitus (DM). PMN membrane fluidity and cytosolic Ca2+ content can be considered markers of PMN activation. In this research we evaluated the PMN membrane fluidity and cytosolic Ca2+ content in VAD subjects with and without type 2 DM and examined the association between these parameters and the mono- or polyvascular localization. We enrolled 155 VAD subjects, including 92 non-diabetic (group A: mean age 63.6 +/- 9.2 years) and 63 diabetic patients (group B: mean age 65.4 +/- 7.8 years). Among group A 63 patients had monovascular …

Vascular atherosclerotic disease type 2 diabetes mellitus polymorphonuclear leukocyte membrane fluidity polymorphonuclear leukocyte Ca2+ contentSettore MED/09 - Medicina Interna
researchProduct

Use of hospital and amubutory data in assessment of screnning, follow-up and complications of diabetes mellitus

2017

Diabetes is a priority health target worldwide. Access to conclusive data is equally a priority in order to establish clear objectives and to implement coordinated action. Medico-administrative databases are being used more and more frequently for this purpose. We set out to illustrate and assess the interest of using a French healthcare consumption database to evaluate screening, surveillance and the risk of acute or chronic complications of diabetes in certain at-risk populations. We concluded that early screening for type-2 diabetes in women with a history of gestational diabetes was inadequate. Although a slight improvement occurred following the recommendations published in 2010, one w…

[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyPmsiDiabète gestationnelGestational diabetes mellitusDonnées médico-AdministrativesDiabète type 2Cardio-Vascular diseasesMaladies cardio-VasculairesType 2 diabetes mellitusHospital dataSchizophreniaSchizophrénie[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyAmbulatory data
researchProduct

Fluidity and cytosolic Ca2+ concentration of circulating polymorphonuclear leukocytes at baseline in some chronic and acute clinical conditions: revi…

2016

Abstract. Objective: In this mini-review we describe the behavior of polymorphonuclear leukocyte (PMN) membrane fluidity and of PMN cytosolic Ca2+ concentration in some chronic and acute clinical conditions. Methods: PMN membrane fluidity was evaluated employing the fluorescent probe Fura-2AM, and PMN cytosolic Ca2+ concentration was evaluated using the fluorescent probe TMA-DPH. Results: From the determination of these two parameters investigated on resting PMNs, an almost constant increase in PMN cytosolic Ca2+ concentration in chronic clinical conditions, such as vascular atherosclerotic disease with and without diabetes mellitus, essential hypertension, chronic kidney disease, and diabe…

acute ischemic strokemedicine.medical_specialtyClinical BiochemistryCell calciumEssential hypertensionBiochemistryInorganic ChemistryCell calcium; membrane fluidity; fluorescence spectroscopy; polymorphonuclear leukocyte; vascular atherosclerotic disease; diabetes mellitus; chronic kidney disease; essential hypertension; myocardial infarction; acute ischemic strokevascular atherosclerotic diseaseDiabetes mellitusInternal medicineCa2 concentrationmedicineMembrane fluidityMyocardial infarctionAcute ischemic strokePolymorphonuclear leukocytediabetes mellitubusiness.industrymembrane fluiditypolymorphonuclear leukocyteessential hypertensionfluorescence spectroscopymedicine.diseaseCytosolmyocardial infarctionCardiologybusinesschronic kidney disease
researchProduct

Empagliflozin Induces White Adipocyte Browning and Modulates Mitochondrial Dynamics in KK Cg-Ay/J Mice and Mouse Adipocytes

2021

Background: White adipose tissue (WAT) browning is a promising target for obesity prevention and treatment. Empagliflozin has emerged as an agent with weight-loss potential in clinical and in vivo studies, but the mechanisms underlying its effect are not fully understood. Here, we investigated whether empagliflozin could induce WAT browning and mitochondrial alterations in KK Cg-Ay/J (KKAy) mice, and explored the mechanisms of its effects.Methods: Eight-week-old male KKAy mice were administered empagliflozin or saline for 8 weeks and compared with control C57BL/6J mice. Mature 3T3-L1 adipocytes were treated in the presence or absence of empagliflozin. Mitochondrial biosynthesis, dynamics, a…

browningmedicine.medical_specialtyfusionChemistrytype 2 diabetes mellitusPhysiologyMFN2AMPKsodium-glucose co-transporter-2 inhibitorWhite adipose tissueMitochondrionThermogeninmitochondrial dynamicsmitochondriamedicine.anatomical_structureEndocrinologyMitochondrial biogenesisPhysiology (medical)Internal medicineBrown adipose tissueEmpagliflozinmedicineQP1-981Original ResearchFrontiers in Physiology
researchProduct

Diabetes and cancer: A critical appraisal of the pathogenetic and therapeutic links.

2014

Diabetes and cancer represent two common, multifactorial, chronic and potentially fatal diseases, not infrequently co-diagnosed in the same patient. Epidemiological data demonstrate significant increases of the cancer incidence in patients with obesity and diabetes, which is more evident for certain site-specific cancers. Although there is increasing evidence that strongly indicates an augmented risk of cancer in diabetic patients, several confounding factors complicate the ability to precisely assess the risk. Mainly in insulin-resistant states (such as in type 2 diabetes mellitus and in metabolic syndrome), direct associations between obesity-related hyperinsulinemia and increasing circul…

business.industryGeneral NeuroscienceType 2 Diabetes MellitusCancerGeneral MedicineReviewmedicine.diseaseBioinformaticsmedicine.disease_causeObesityGeneral Biochemistry Genetics and Molecular Biologyinsulin-resistant stateanti-cancer drugdiabeteDiabetes mellitusanti-diabetic medicationmedicineHyperinsulinemiacancerGeneral Pharmacology Toxicology and PharmaceuticsMetabolic syndromeAdverse effectCarcinogenesisbusinessriskBiomedical reports
researchProduct

Diet Rich in Plant Protein May Prevent Type 2 Diabetes

2020

Purpose : The aim is to show the ideal protein quality and quantity and the dietary composition for the prevention and metabolic control of type 2 diabetes mellitus (T2DM). Introduction Although some reviews demonstrate the advantages of a diet with a higher protein intake, other reviews have observed that a diet high in carbohydrates, with low-glycaemic index carbohydrates and good fibre intake, is equally effective in improving insulin sensitivity. Methods Over 2831 articles were screened, and 24 from the last 5 years were analysed and summarised for this review, using the protein, diabetes and insulin glucose metabolic keywords in Pubmed in June 2019. Results Eleven studies demonstrate t…

business.industryInsulinmedicine.medical_treatmentType 2 Diabetes MellitusType 2 diabetesmedicine.diseasePlant proteinMetabolic control analysisDiabetes mellitusmedicineFood scienceMetabolic syndromebusinessProtein qualityProceedings of The 1st International Electronic Conference on Plant Science
researchProduct

Cardiovascular Health in Migrants. Current status and issues for prevention. A Collaborative Multidisciplinary Task Force Report

2014

OBJECTIVES: To review information on cardiovascular health and migration, to stress the attention of researchers that much needs to be done in the collection of sound data in Italy and to allow policy makers identifying this issue as an important public health concern. BACKGROUND: In Italy, the rate of immigrants in the total number of residents increased from 2.5% in 1990 to 7.4% in 2010, and currently exceeds 10% in regions such as Lombardia, Emilia Romagna and Toscana. METHODS: A consensus statement was developed by approaching relevant Italian national scientific societies involved in cardiovascular prevention. Task force members were identified by the president and/or the boards of eac…

cardiovascular riskMalemedicine.medical_specialtyEconomic growthcardiovascular risk; ethnic; ethnicity; global health; immigration; migrant; minorities; Cardiovascular Diseases; Diabetes Mellitus; Europe; Female; Health Status; Humans; Kidney Diseases; Male; Overweight; Transients and Migrants; Cardiology and Cardiovascular Medicine; Medicine (all)Kidney Diseasemedia_common.quotation_subjectHealth StatusImmigrationEthnic groupglobal healthHealth StatuminoritieCardiovascular DiseaseGlobal healthmedicineDiabetes Mellitusmedia_common.cataloged_instanceHumansEuropean unionethnicmedia_commonTransients and Migrantscardiovascular risk ethnic ethnicity global health immigration migrant minoritiesbusiness.industryPublic healthMedicine (all)Diabetes MellituGeneral MedicineOverweightminoritiesSettore MED/11 - Malattie Dell'Apparato CardiovascolareEuropemigrantCardiovascular Diseasesethnic; global health; immigration; migrant; minorities; cardiovascular risk; ethnicitySurvey data collectionethnicitySocial exclusionKidney DiseasesFemalebusinessCardiology and Cardiovascular MedicineDiversity (politics)immigrationHuman
researchProduct

Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes

2022

The current management of Type 2 Diabetes Mellitus (T2DM) includes incretin-based treatments able to enhance insulin secretion and peripheral insulin sensitivity as well as improve body mass, inflammation, plasma lipids, blood pressure, and cardiovascular outcomes. Dietary Free Fatty Acids (FFA) regulate metabolic and anti-inflammatory processes through their action on incretins. Selective synthetic ligands for FFA1-4 receptors have been developed as potential treatments for T2DM. To comprehensively review the available evidence for the potential role of FFA receptor agonists in the treatment of T2DM, we performed an electronic database search assessing the association between FFAs, T2DM, i…

cardiovascular riskMedicine (General)Cardiovascular risk Free fatty acidsGLP-1 Incretins Metabolism Type 2 diabetes Fatty Acids Nonesterified Humans Diabetes Mellitus Type 2 Insulin Resistanceendocrine system diseasesfree fatty acidsType 2 diabetesReviewGeneral MedicineFatty Acids NonesterifiedR5-920Diabetes Mellitus Type 2HumansInsulin ResistanceGLP-1metabolismincretinsMedicina
researchProduct

Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes

2020

Type 2 Diabetes Mellitus (T2DM) is associated with a high risk of atherosclerotic cardiovascular (CV) disease. Among the well-known pathophysiologic factors, crucial roles are played by endothelial dysfunction (caused by oxidative stress and inflammation hyperglycemia-linked), increased activity of nuclear factor kB, altered macrophage polarization, and reduced synthesis of resident endothelial progenitor cells. As consequence, a potentially rapid progression of the atherosclerotic disease with a higher propensity to unstable plaque is arguable, finally leading to significantly increased cardiovascular mortality. Main managements are focused on both prevention and early diagnosis, by target…

cardiovascular riskcardiovascular risk; dipeptidyl peptidase-4 inhibitors; glucagon like peptide-1 receptor agonists; sodium glucose cotransporter-2 inhibitors; type 2 diabetes mellitustype 2 diabetes mellitusglucagon like peptide-1 receptor agonistslcsh:Medicine030209 endocrinology & metabolismInflammationType 2 diabetesDiseaseReview030204 cardiovascular system & hematologyHypoglycemiaBioinformaticsmedicine.disease_cause03 medical and health sciences0302 clinical medicinemedicineEndothelial dysfunctionAdverse effectbusiness.industrylcsh:RType 2 Diabetes MellitusGeneral Medicinemedicine.diseasesodium glucose cotransporter-2 inhibitorsmedicine.symptombusinessdipeptidyl peptidase-4 inhibitorsOxidative stressJournal of Clinical Medicine
researchProduct